SaVipharm kicks off construction of high-tech R&D centre
The SaVi Pharmaceutical Joint Stock Company (SaVipharm) held a ceremony on January 9 to receive the EU GMP Certificate and kick off construction of a high-tech R&D centre in HCM City.
HCM City (VNA) – The SaVi Pharmaceutical Joint Stock Company (SaVipharm) held a ceremony on January 9 to receive the EU GMP Certificate and kick off construction of a high-tech R&D centre in District 7, Ho Chi Minh City.
On November 28, 2019, the European Community Competent Authority granted the EU GMP Certificate for SaVipharm's Pharmaceutical Factory and Oral Solid Dosage (OSD) Factory for achieving both two leading high standards in the system of pharmaceutical manufacture standards: Japanese GMP and EU GMP.
Following the achievements in science and technology activities, SaVipharm has set strategic goals for the new development period of 2020 - 2025. Accordingly, it will continue to prioritize investment in trained human resources and finance resources for science & technology and R&D activities, and the breakthrough stage is to invest in building the High-tech R&D Center.
The center will focus on research new and high technology product groups, receiving and transfering new products - new technology, boosting domestic and international cooperation in Scientific Research – Research & Development.
In addition to the equipment of the center, the OSD Factory will be invested in the corresponding industrial production equipment, ensuring that the results of R&D activities at the center are quickly put into commercial production after being approved.
SaVipharm was founded in August 2005 by Meritorious Doctor, Pharmacist Specialist II Tran Tuu (former General Director of the Vietnam Pharmaceutical Corporation). Since its inception, the company has focused its resources on investing in an Oral Solid Dosage (OSD) factory with synchronous and modern production lines and equipment, new technologies. It has also invested in facilities for scientific research and R&D activities.
🥃 SaVipharm is one of the few pharmaceutical enterprises eligible to be granted the Certificate of Science and Technology Enterprise (according to Decree No. 80/2007/NĐ-CP dated May 19, 2017 and Decree No. 13/2019/NĐ-CP dated February 1, 2019 of the Prime Minister) with 178 recognized products./.
The 14th International Exhibition on Products and Supplies for Medical, Pharmaceutical, Hospital and Rehabilitation (Pharmed and Healthcare Vietnam 2019) opened in Ho Chi Minh City on September 11, featuring more than 600 booths by exhibitors from 25 countries and territories worldwide.
The 26th Vietnam International Medical, Hospital and Pharmaceutical Exhibition (Vietnam Medipharm Expo) will take place from December 5-7 in Hanoi, attracting 180 domestic and foreign exhibitors.
The 26th Vietnam International Medical, Hospital and Pharmaceutical Exhibition (Vietnam Medipharm Expo) opened in Hanoi on December 5, attracting 180 exhibitors from 18 countries and territories.
A delegation of Vietnamese pharmacists, doctors and businessmen attended the International Exhibition & Conference on AYUSH & Wellness in New Delhi, India from December 19-22.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
At the ceremony (Photo: SaVipharm)
